Eight Will Co., Ltd. (Headquarters: Shibuya-ku, Tokyo, Representative: Shota Tanaka, hereinafter "Eight Will"), the exclusive domestic distributor of the gluten-degrading lactic acid bacteria "Digulact," is pleased to announce the appointment of Mitsuaki Ishioka, a specialist in digestive endoscopy, as our Medical Advisor. This appointment as Medical Advisor was realized through Mr. Ishioka's interest in Eight Will's philosophy and business. Eight Will aims to create a world where health can be chosen more simply and freely through innovative solutions based on scientific evidence. Currently, as the exclusive domestic distributor of the gluten-degrading lactic acid bacteria "Digulact," we are broadly engaged in supplying raw materials (for supplements and cooking) to food manufacturers and bakeries, as well as selling our own brand products. Our representative, Shota Tanaka, engaged in repeated exchanges of opinions with Mr. Ishioka, sharing Eight Will's direction and business development, which led to Mr. Ishioka's appointment as Medical Advisor. Mr. Ishioka is also active as an influencer on his Instagram account "Tokyo Pan Life." (東京パン生活。), introducing delicious bread in Tokyo. Moving forward, we will incorporate Mr. Ishioka's medical expertise into our business, sharing information and cutting-edge know-how related to gluten and wheat-based foods, and broadly proposing a "gluten control habit" for skillfully managing gluten to "continue eating wheat-based foods deliciously and healthily." Our original gluten-degrading lactic acid bacteria supplement "De-glu" has begun to be handled at "Nihonbashi Ningyocho Gastroenterology and Endoscopy Clinic," where Mr. Ishioka serves as director. It is supported as a new option for enjoying wheat-based foods like bread and pasta "when you want to eat them, with as little burden as possible," rather than a life of "constant self-denial." ■Profile of Mitsuaki Ishioka Mitsuaki Ishioka Doctor: Specialist in Gastroenterology. Dire